TL1A Aggravates Cytokine-Induced Acute Gut Inflammation and Potentiates Infiltration of Intraepithelial Natural Killer Cells in Mice

Inflamm Bowel Dis. 2019 Feb 21;25(3):510-523. doi: 10.1093/ibd/izy351.

Abstract

Background: The tumor necrosis factor alpha (TNFα)-homologous cytokine TL1A is emerging as a major player in intestinal inflammation. From in vitro experiments on human lymphocytes, TNF-like molecule 1A (TL1A) is known to activate a highly inflammatory lymphoid response in synergy with interleukin (IL)-12 and IL-18. Carriers of specific genetic polymorphisms associated with IL-12, IL-18, or TL1A signaling have increased Crohn's disease risk, and all 3 cytokines are upregulated during active disease. The study aim was to investigate whether the type 1-polarizing cytokines IL-12 and IL-18 could directly initiate intestinal pathology in mice and how TL1A would influence the resulting inflammatory response.

Methods: Conventional barrier-bred and germ-free mice were randomly allocated to different groups and injected twice with different combinations of IL-12, IL-18, and TL1A, and killed 3 days after the first injection. All treatment groups were co-housed and fed a piroxicam-supplemented chow diet.

Results: Intestinal pathology was evident in IL-12- and IL-18-treated mice and highly exacerbated by TL1A in both the colon and ileum. The cytokine-induced intestinal inflammation was characterized by epithelial damage, increased colonic levels of TNFα, IL-1β, IFN-γ, and IL-6, and various chemokines along with gut microbiota alterations exhibiting high abundance of Enterobacteriaceae. Furthermore, the inflamed ileum and colon exhibited a TL1A-specific increased infiltration of intraepithelial natural killer cells co-expressing NKG2D and IL-18Ra and a higher frequency of unconventional T cells in the colonic epithelium. Upon cytokine injection, germ-free mice exhibited similar intraepithelial lymphoid infiltration and increased colonic levels of IFNγ and TNFα.

Conclusions: This study demonstrates that TL1A aggravates IL-12- and IL-18-induced intestinal inflammation in the presence and absence of microbiota.

Keywords: NKG2D; cytokine synergy; intraepithelial lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Epithelial Cells / drug effects
  • Epithelial Cells / immunology*
  • Epithelial Cells / microbiology
  • Female
  • Gastrointestinal Tract / drug effects
  • Gastrointestinal Tract / immunology*
  • Gastrointestinal Tract / microbiology
  • Inflammation / etiology*
  • Inflammation / metabolism
  • Inflammation / pathology
  • Interleukin-12 Subunit p35 / administration & dosage*
  • Interleukin-18 / administration & dosage*
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / immunology
  • Intestinal Mucosa / microbiology
  • Killer Cells, Natural / drug effects
  • Killer Cells, Natural / immunology*
  • Killer Cells, Natural / microbiology
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Tumor Necrosis Factor Ligand Superfamily Member 15 / physiology*

Substances

  • Il12a protein, mouse
  • Interleukin-12 Subunit p35
  • Interleukin-18
  • Tnfsf15 protein, mouse
  • Tumor Necrosis Factor Ligand Superfamily Member 15